Cell line development plays an essential role in in a variety of research and development applications such as recombinant protein production, assay development, drug development and screening as well as functional studies.
Since 2000, our highly skilled and experienced scientific team has worked with dozens of human and non-human cell lines and has successfully generated hundreds of cell lines for different research applications and production of therapeutic proteins. trenzyme will provide you with cell lines at the highest quality standards and with maximum efficiency to save you valuable research time and money.
Our scientific experts developed a high-titer cGMP-compliant production cell line to support the COVID-19 research. This stable cGMP compliant cell line for SARS-CoV-2 Spike S1 Protein (RBD) is available on request and comes with an already developed downstream process and analytical methods. The cell bank, process data and even purified protein can be shipped with short delivery time.
trenzyme’s R&D department is continuously working on the expansion of our cell lines. As soon as more cell lines are available off-the-shelf, we will place them in our webshop trenzyme.shop.
Get more information about our cGMP compliant production cell line for SARS-CoV-2 Spike S1 Protein (RBD)